Medical Univeristy Vienna

Vienna 1090

1 studies enrolling now · 2 studies all time

What they study most

Gastroesophageal Junction Adenocarcinoma, Marginal Zone Lymphoma, Metastatic Gastric Adenocarcinoma, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling